1 Introduction to Research & Analysis Reports
1.1 mRNA Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global mRNA Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global mRNA Vaccines Overall Market Size
2.1 Global mRNA Vaccines Market Size: 2023 VS 2030
2.2 Global mRNA Vaccines Market Size, Prospects & Forecasts: 2023-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key mRNA Vaccines Players in Global Market
3.2 Global Companies mRNA Vaccines Product & Technology
4 mRNA Vaccines Companies Profiles
4.1 MODERNA
4.1.1 MODERNA Company Summary
4.1.2 MODERNA Business Overview
4.1.3 MODERNA mRNA Vaccines Product Offerings & Technology
4.1.4 MODERNA mRNA Vaccines R&D, and Plans
4.2 Pfizer
4.2.1 Pfizer Company Summary
4.2.2 Pfizer Business Overview
4.2.3 Pfizer mRNA Vaccines Product Offerings & Technology
4.2.4 Pfizer mRNA Vaccines R&D, and Plans
4.3 Zydus Cadila
4.3.1 Zydus Cadila Company Summary
4.3.2 Zydus Cadila Business Overview
4.3.3 Zydus Cadila mRNA Vaccines Product Offerings & Technology
4.3.4 Zydus Cadila mRNA Vaccines R&D, and Plans
4.4 Fosun Pharmaceutical
4.4.1 Fosun Pharmaceutical Company Summary
4.4.2 Fosun Pharmaceutical Business Overview
4.4.3 Fosun Pharmaceutical mRNA Vaccines Product Offerings & Technology
4.4.4 Fosun Pharmaceutical mRNA Vaccines R&D, and Plans
4.5 CureVac
4.5.1 CureVac Company Summary
4.5.2 CureVac Business Overview
4.5.3 CureVac mRNA Vaccines Product Offerings & Technology
4.5.4 CureVac mRNA Vaccines R&D, and Plans
4.6 Stemirna
4.6.1 Stemirna Company Summary
4.6.2 Stemirna Business Overview
4.6.3 Stemirna mRNA Vaccines Product Offerings & Technology
4.6.4 Stemirna mRNA Vaccines R&D, and Plans
5 Sights by Region
5.1 By Region - Global mRNA Vaccines Market Size, 2024 & 2030
5.2 By Region - Global mRNA Vaccines Revenue, (2024-2030)
5.3 United States
5.3.1 Key Players of mRNA Vaccines in United States
5.3.2 United States mRNA Vaccines Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of mRNA Vaccines in Europe
5.4.2 Europe mRNA Vaccines Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of mRNA Vaccines in China
5.5.2 China mRNA Vaccines Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global mRNA Vaccines Market Size Markets, 2024 & 2030
6.2 Being Developed
6.3 Preclinical
6.4 Clinical I
6.5 Clinical II
7 Sights by Application
7.1 By Application - Global mRNA Vaccines Market Size, 2024 & 2030
7.2 COVID-19
7.3 Cancer
7.4 Infectious Disease Treatment MRNA Vaccine
7.5 Infection Prevention MRNA Vaccine
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
